Tests a drug-coated balloon to stabilize clogged heart arteries
Part of Heart & circulation clinical trials.
This trial studies whether a drug-coated balloon can better treat new, narrowed spots in multiple coronary arteries and “stabilize” the plaque. It may help improve blood flow after a procedure called balloon angioplasty for selected patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have significant blockage in more than one coronary artery and need a procedure to reopen them
- Your new (de novo) narrowing is in a small-to-medium artery size (about 2.25 to 4.0 mm)
- The narrowed spot can be evaluated with an inside-the-artery imaging test during the procedure
- You must be able to sign a consent form to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug-coated balloon (DCB) that releases two medicines (sirolimus and paclitaxel) to open blocked small heart arteries. It may help people with stable chest pain or recent, controlled heart events who have a narrowed small vessel.
This trial is looking at how well a special balloon that releases medicine works to open blocked heart arteries. It may help people who have not had a stent placed in the same spot before.
This trial tests a special balloon coated with medicine to open blocked coronary arteries (blood vessels to the heart). The procedure uses ultrasound and imaging guidance to help doctors decide whether to use the drug-coated balloon alone, which may reduce the need for stents and future complications.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
This trial studies a balloon treatment coated with medicine (to help keep the artery open) for people with coronary artery disease. You may be a candidate if you are planned to receive this type of procedure and do not have certain key safety risks.
This study looks at how to treat blocked heart arteries that have narrowed again after a prior drug-eluting stent. It compares using another drug-eluting stent versus a drug-coated balloon, chosen based on an imaging scan inside the artery (OCT), to reduce repeat narrowing.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.